Brief: Enveric Biosciences Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
28/01/2026 23:11
Jan 28 (Reuters) - Enveric Biosciences Inc ENVB.O: ENVERIC BIOSCIENCES ANNOUNCES CLOSING OF $1.5 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES Source text: ID:nBw2wBpg5a Further company coverage: ENVB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003